Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

2024 SMR Congress Insights: Key Takeaways of Important Trials in Mel…

Roswell Park Comprehensive Cancer Center

I. Puzanov

The TAPUR Study: Evaluating Targeted Therapies Based on Genetic Alte…

University of Miami Sylvester Comprehensive Cancer Center

R. Schilsky

Oncologic Emergencies: The Clock Is Ticking

Medical College of Georgia - Augusta University

G. Raval

T-Cell Exhaustion in Chronic Viral Infection and Cancer: Implication…

Yale Cancer Center

R. Ahmed

Successes and Challenges of Early Drug Development for Brain Metasta…

MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

A. Drilon

Breaking Boundaries: The Science Behind Immune Tolerance in Cancer

Yale Cancer Center

M. Mamula, E. Winer

Identifying and Targeting DNA Repair Mutations in Cancer

Yale Cancer Center

S. Ganesan

Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forw…

Oncology Data Advisor

J. Mouabbi, R. Maclean, M. Glover

Blood Cancers Basics

Masonic Cancer Center, University of Minnesota

Z. Sachs

HPV Vaccination: Safety, Efficacy, and Importance

GRACE

P. Romesser

Impact of Chronic Stress on Solid Tumor Growth and Immune Response V…

Ben Switzer

Integrating Germline Pharmacogenomic Testing Into Oncology Care

UNC Lineberger Comprehensive Cancer Center

A. Cipriani

Drug Development in Melanoma: Phase I/II/III vs. Novel Designs

Melanoma Bridge 2023

I. Puzanov

Therapeutic Targeting of Epigenetic Mechanisms in Cancer

Yale Cancer Center

S. Armstrong

Solid Tumor Pharmacy Updates

Total Health

M. Quinn

The Common Sense Movement in Oncology

ecancer

V. Vanderpuye

Drug Development in Melanoma: Why Do We Need Novel Trial Designs?

Melanoma Bridge 2023

M. Khasraw

2023 ASCO® Direct Philadelphia: Complementary & Integrative Therapie…

Total Health

B. DuPree

Tumor-Infiltrating Lymphocytes for Clinicians

Houston Methodist

S. Ganguly